Stay updated on Pembrolizumab in Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Glioblastoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Footer now shows 'Revision: v3.3.3'; 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' have been removed.
    Difference
    0.1%
    Check dated 2025-12-23T09:31:28.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    Footer Revision notice updated from v3.3.1 to v3.3.2. This is a minor UI/metadata change and does not affect any study details, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2025-12-01T17:13:34.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision: v3.3.1 updates the page version from v3.2.0. The study details page appears unchanged in content, with no new or altered clinical information visible.
    Difference
    0.1%
    Check dated 2025-11-24T14:34:22.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The government funding operating status notice was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:37:57.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    The new screenshot shows an updated last update date (May 13, 2025) and minor formatting changes. There are no substantive changes to the study design, eligibility criteria, primary or secondary outcomes, or reported results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:13:43.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    2%
    Check dated 2025-10-05T10:16:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Glioblastoma Clinical Trial page.